Risk factors for cytomegalovirus infection and disease after kidney transplantation: A meta-analysis

The burden of cytomegalovirus infection remains high in high‐risk kidney transplant recipients despite six‐month valganciclovir prophylaxis

(2021) Juulia Räihä et al.   Transplant Infectious Disease

Delayed graft function and rejection are risk factors for cytomegalovirus breakthrough infection in kidney transplant recipients

(2021) Wieteke Kleinherenbrink et al.   PHARMACOLOGICAL RESEARCH

Cytomegalovirus in renal transplant recipients from living donors with and without valganciclovir prophylaxis and with immunosuppression based on anti-thymocyte globulin or basiliximab

(2021) Jorge Andrade-Sierra et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Clinical Characteristics of Late-Onset Cytomegalovirus Infection After Kidney Transplantation

(2021) Sirapob Nuansri et al.   TRANSPLANTATION PROCEEDINGS

Cytomegalovirus infection in kidney transplant patients: Prevalence, risk factors, and impact on outcome – A local multicentre experience

(2021) Maroun Abou-Jaoudé et al.   TRANSPLANT IMMUNOLOGY

Cytomegalovirus Experience in Pediatric Kidney Transplantation in 26 Years’ Time

(2020) Ahmet Keskinoglu et al.   TRANSPLANTATION PROCEEDINGS

A split strategy to prevent cytomegalovirus after kidney transplantation using prophylaxis in serological high‐risk patients and a pre‐emptive strategy in intermediate‐risk patients: Combining the best of two options?

(2020) Rachel Hellemans et al.   Transplant Infectious Disease

Increased incidence and unusual presentations of CMV disease in kidney transplant recipients after conversion to belatacept

(2020) Nathalie Chavarot et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Killer Immunoglobulin-Like Receptor 2DS2 (KIR2DS2), KIR2DL2-HLA-C1, and KIR2DL3 as Genetic Markers for Stratifying the Risk of Cytomegalovirus Infection in Kidney Transplant Recipients

(2019) Dominika Deborska-Materkowska et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Cytomegalovirus in solid organ transplant recipients—Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice

(2019) Raymund R. Razonable et al.   CLINICAL TRANSPLANTATION

Incidence and risk factors associated with cytomegalovirus infection after thetreatment of acute rejection during the first year in kidney transplant recipients receiving preemptive therapy

(2019) Claudia Felipe et al.   Transplant Infectious Disease

Safety considerations with current and emerging antiviral therapies for cytomegalovirus infection in transplantation

(2019) Guy El Helou et al.   Expert Opinion On Drug Safety

Age matters: older age as a risk factor for CMV reactivation in the CMV serostatus–positive kidney transplant recipient

(2019) Marion Hemmersbach-Miller et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Burden and Timeline of Infectious Diseases in the First Year After Solid Organ Transplantation in the Swiss Transplant Cohort Study

(2019) Christian van Delden et al.   CLINICAL INFECTIOUS DISEASES

Revisiting cytomegalovirus serostatus and replication as risk factors for inferior long-term outcomes in the current era of renal transplantation

(2019) Nicole Bischof et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

The Aquaporin 5 −1364A/C Promoter Polymorphism Is Associated With Cytomegalovirus Infection Risk in Kidney Transplant Recipients

(2019) Tim Rahmel et al.   Frontiers in Immunology

Diagnostic utility of monitoring cytomegalovirus-specific immunity by QuantiFERON-cytomegalovirus assay in kidney transplant recipients

(2018) Dominika Deborska-Materkowska et al.   BMC INFECTIOUS DISEASES

Cytomegalovirus prophylaxis in seropositive renal transplant recipients receiving thymoglobulin induction therapy: Outcome and risk factors for late CMV disease

(2018) Jose O. Reusing et al.   Transplant Infectious Disease

Prevention of Late-Onset Cytomegalovirus Infection and Disease in Donor-Positive/Recipient-Negative Kidney Transplant Recipients Using Low-Dose Valganciclovir

(2018) K. Nanmoku et al.   TRANSPLANTATION PROCEEDINGS

Late CMV infections after kidney transplantation under the preemptive strategy: risk factors and clinical aspects

(2018) Gislaine Ono et al.   Transplant Infectious Disease

Primary Cytomegalovirus Infection in Seronegative Kidney Transplant Patients Is Associated with Protracted Cold Ischemic Time of Seropositive Donor Organs

(2017) Fabian Schlott et al.   PLoS One

Fewer cytomegalovirus complications after kidney transplantation byde novouse of mTOR inhibitors in comparison to mycophenolic acid

(2016) J. Radtke et al.   Transplant Infectious Disease

Incidence and Risk Factors for Cytomegalovirus Infection in Patients With Kidney Transplantation: A Single-Center Experience

(2016) S. Feng et al.   TRANSPLANTATION PROCEEDINGS

Two-year post-transplantation cytomegalovirus DNAemia in asymptomatic kidney transplant recipients: incidence, risk factors, and outcome

(2015) B. Viot et al.   Transplant Infectious Disease

Incidence, Risk Factors and Outcomes of Delayed-onset Cytomegalovirus Disease in a Large Retrospective Cohort of Lung Transplant Recipients

(2015) Carlos A. Q. Santos et al.   TRANSPLANTATION

Risk Factors of Cytomegalovirus Disease in Kidney Transplant Recipients: A Single-Center Study in Thailand

(2015) T. Chiasakul et al.   TRANSPLANTATION PROCEEDINGS

Do we need to worry about mycophenolate overdose?

(2014) Guido Filler et al.   Expert Opinion On Drug Safety

Prevention strategies for cytomegalovirus disease and long-term outcomes in the high-risk transplant patient (D+/R−): experience from the RESITRA-REIPI cohort

(2014) Y. Meije et al.   Transplant Infectious Disease

Delayed-Onset Cytomegalovirus Disease Coded During Hospital Readmission After Kidney Transplantation

(2014) Carlos A. Q. Santos et al.   TRANSPLANTATION

Incidence and Risk Factors for Cytomegalovirus Disease in a Colombian Cohort of Kidney Transplant Recipients

(2014) J. Díaz et al.   TRANSPLANTATION PROCEEDINGS

Critical analysis of valganciclovir dosing and renal function on the development of cytomegalovirus infection in kidney transplantation

(2013) M.A. Posadas Salas et al.   Transplant Infectious Disease

Cytomegalovirus disease in African-American kidney transplant patients

(2012) J. McGee et al.   Transplant Infectious Disease

Cytomegalovirus Disease in Kidney Transplant Recipients: Incidence, Clinical Profile, and Risk Factors

(2012) E. Cordero et al.   TRANSPLANTATION PROCEEDINGS

Cytomegalovirus Viremia After Kidney Transplantation in Thailand: Predictors of Symptomatic Infection and Outcome

(2012) S.P. Watcharananan et al.   TRANSPLANTATION PROCEEDINGS

Six-Month Low-Dose Valganciclovir Prophylaxis in Cytomegalovirus D+/R− Kidney Transplant Patients Receiving Thymoglobulin Induction

(2012) F.L. Luan   TRANSPLANTATION PROCEEDINGS

New Developments in the Management of Cytomegalovirus Infection after Solid Organ Transplantation

(2010) Albert J. Eid et al.   DRUGS

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

(2010) Andreas Stang   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Association between a polymorphism in the human programmed death-1 (PD-1) gene and cytomegalovirus infection after kidney transplantation

(2009) T. W. Hoffmann et al.   JOURNAL OF MEDICAL GENETICS

Cytomegalovirus Infection and Disease Following Renal Transplantation: Preliminary Report of Incidence and Potential Risk Factors

(2009) M. Taherimahmoudi et al.   TRANSPLANTATION PROCEEDINGS

Cytomegalovirus Infection Renal Transplant Recipients: Risk Factors and Outcome

(2009) J. Kanter et al.   TRANSPLANTATION PROCEEDINGS

Aspects of Immune Dysfunction in End-stage Renal Disease

(2008) S. Kato et al.   Clinical Journal of the American Society of Nephrology